In enteric bacteria, carbamyl phosphate synthesis is catalyzed by a single enzyme (glutaminedependent carbamyl phosphate synthetase; 1) which is coded for by the gene pyrA. Mutant forms of pyrA that produce enzymatically inactive or no protein result in a double requirement for arginine and pyrimidine (5) . Carbamyl phosphate synthetase from Escherichia coli has been reported to be sensitive to feedback inhibition by uridine-5'-phosphate (UMP), and ornithine has been reported to antagonize this inhibition (6) . However, our results with 320-fold purified enzyme from Salmonella typhimurium strain LT-2 have established that ornithine activates the enzyme through the reduction of the apparent Km for adenosine triphosphate (ATP) (in preparation). Results with dialyzed crude extracts of E. coli B/r (Table 1) suggest that here, too, ornithine is a direct activator. The intracellular concentration of the activator ornithine is set both by arginine through feedback inhibition of glutamate acetylase and by the availability of carbamyl phosphate (Fig. 1) .
Two other phenotypes have been shown to result from mutations in the pyrA gene. Mutant strains (urs) which produce carbamyl phosphate synthetase that is insensitive to ornithine and hypersensitive to UMP grow in minimal medium and in minimal media plus arginine or plus arginine and uracil, but are unable to grow in minimal medium plus uracil (5). Eisenstark described a third phenotype resulting from mutation in pyrA in S. typhimurium (3) . The strain grows in minimal medium and fails to grow in minimal medium plus arginine. This mutation (ars) results in the production of a carbamyl phosphate synthetase which has altered regulatory properties (unpublished results). In this paper, we report a fourth phenotype resulting from mutation in pyrA, namely, the single requirement of arginine for growth (Table 2) . In the course of a search for genetic markers near pyrA, we investigated two arginine auxotrophs of E. coli B/r (SB5015 and SB1626) which had the properties of strains lacking ornithine trans- (8) .
wild-type strain ( Table 3 ). The two strains contain carbamyl phosphate synthetase activity (as would be expected since they grow in the absence of an exogenous source of pyrimidine), but the level of activity is low, thus suggesting the production of an altered product of the pyrA gene.
Mapping experiments support the hypothesis that the mutations are in pyrA. Using phage Plbt grown on wild-type, tranductions of thr+ to the mutants SB5015 and SB1626, which also carry the thr-1 marker, were carried out; 44% (183 out of 437) of the thr+ tranductants of SB5015 were arginine prototrophs. (Cotransduction between thr and this mutation, suspected to be argF, was originally observed by E. Englesberg.) This frequency of cotransduction is quite close to that (46 %, 226 out of 516) between thr-l and a known pyrA marker, in strain SB5013 which requires arginine and pyrimidine for growth and lacks detectable levels of carbamyl phosphate synthetase activity; argF is over 4 min away from pyrA, a distance too great to allow cotransduction by phage P1 (7). The arginine auxotrophic character of SB1626 is also contransduced with thr-I [100% (300 out of 300), with arginine as the selected marker, and 28% (198 out of 540) with threonine as the selected marker].
Although strains SB5015 and SB1626 form colonies on plates of minimal medium supplemented only with arginine, measurements of growth rate in liquid media established that neither strain grows at full rate in media supplemented only with arginine. If the medium is supplemented with both arginine and uracil, both mutants grow at the same rate as the wild-type (Table 3) . However, the stimulation of growth rate by pyrimidine is probably not a reliable character for distinguishing mutations in pyrA from those in argF. Although growth rate of SB5015 is stimulated 1.7-fold by pyrimidine, SB1626 is stimulated only 1.1-fold, a factor close to the limits of experimental error. It is possible a Ornithine transcarbamylase (OTCase) assay. Cells were filtered, washed, and suspended in 0.05 M glycylglycine buffer (pH 8.5). Toluene (0.04 ml) was added, and the cells were incubated at 37 C for 30 min. The toluene-treated suspension was mixed with S j,moles of MgCl2, 5 ,umoles of L-ornithine, 7.5 ,moles of freshly prepared lithium carbamyl phosphate, and enough buffer to make the total volume 3 ml. After incubating for 30 min, the reaction was stopped by the addition of 5 ml of 0.5 M perchloric acid. The precipitate was removed by centrifugation, and citrulline was determined in a sample of the supernatant fluid by the colorimetric method of Gerhart and Pardee (4). Specific activity is expressed as micromoles of citrulline synthesized per hour per milligram (dry weight). Carbamyl phosphate synthetase (CPSase) activity was assayed by the method of Anderson and Meister (2) . Specific activity is expressed as micromoles of 14C-carbamyl phosphate synthesized per hour per milligram of protein.
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